Skandinaviska Enskilda Banken Ab (Publ) Castle Biosciences Inc Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$50.07 - $76.78 $415,581 - $637,274	-8,300 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$38.47 - $52.03 $153,880 - $208,120	-4,000 Reduced 32.52%	8,300 $427,000
Q2 2020 Aug 13, 2020	BUY	$27.28 - $43.01 $335,544 - $529,023	12,300 New	12,300 $464,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.